CIP-NET AWARDEES
UG3 CIP-NET Research Centers
UG3CA290454
Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers
MD Anderson Cancer Center, University of Houston - MPI
PI: Isabelle Bedrosian, MPI: Anjana Bhardwaj, MPI: Preethi Gunaratne
UG3CA290300
Immunosurveillance of breast glands with oncogenic germline mutations
Massachusetts General Hospital
PI: Shadmehr Demehri
UG3CA290443
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer
University Of Arizona
PI: Sally E. Dickinson, MPI: Clara Curiel-Lewandrowski
UG3CA290517
Immune determinants modulating cancer development in Lynch Syndrome
Icahn School of Medicine at Mount Sinai
PI: Nina Bhardwaj, MPI: Aimee Lucas, MPI: Robert Samstein
UG3CA301294
Engineered probiotic bacteria for colorectal cancer immunoprevention and interception
Columbia University Health Sciences
PI: Nicholas Arpaia, MPI: Tal Danino
UG3CA290302
Targeting microbial triggers of gammopathy for immunoprevention
Fred Hutchinson Cancer Center
PI: Madhav Dhodapkar, MPI: Richard Flavell, MPI: Noah Palm
UG3CA290305
Developing a novel agonist of CD137 for cancer immunoprevention
University of Missouri - Columbia
PI: Haval Shirwan, MPI: Esma Yolcu
UG3CA290468
Preclinical studies for the immunoprevention of multiple myeloma
Mayo Clinic Arizona
PI: Peter Leif Bergsagel, MPI: Marta Chesi
CIP-NET Coordinating Center
U24CA30562
Cancer Immunoprevention Network (CIP-Net) Data and Resource Coordinating Center
Roswell Park Comprehensive Cancer Center, Weill Cornell Medicine
PI: Alan Hutson, MPI: Song Liu, MPI: Steven Lipkin
NCI CIP-Net Program Leadership
Altaf Mohammed, Ph.D.
NCI Division of Cancer Prevention,
Chemopreventive Agent Development Research Group
Lillian Kuo, Ph.D.
NCI Division of Cancer Biology,
Cancer Immunology, Hematology, and Etiology Branch